Quantum Biopharma Stock Technical Analysis
| QNTM Stock | 4.00 0.03 0.74% |
As of the 5th of February, Quantum BioPharma holds the Variance of 89.63, coefficient of variation of (721.29), and Risk Adjusted Performance of (0.09). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Quantum BioPharma, as well as the relationship between them. Please check Quantum BioPharma mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and kurtosis to decide if Quantum BioPharma is priced some-what accurately, providing market reflects its current price of 4.0 per share. Given that Quantum BioPharma has information ratio of (0.15), we recommend you to check out Quantum BioPharma's recent market performance to make sure the company can sustain itself at a future point.
Quantum BioPharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Quantum, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to QuantumQuantum BioPharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Will Biotechnology sector continue expanding? Could Quantum diversify its offerings? Factors like these will boost the valuation of Quantum BioPharma. Anticipated expansion of Quantum directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Quantum BioPharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Quantum BioPharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Quantum BioPharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Quantum BioPharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Quantum BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Quantum BioPharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Quantum BioPharma.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Quantum BioPharma on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Quantum BioPharma or generate 0.0% return on investment in Quantum BioPharma over 90 days. Quantum BioPharma is related to or competes with Reviva Pharmaceuticals, Annovis Bio, Cumberland Pharmaceuticals, PolyPid, Rockwell Medical, Rein Therapeutics, and Celularity. Quantum BioPharma is entity of United States More
Quantum BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Quantum BioPharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Quantum BioPharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 59.29 | |||
| Value At Risk | (12.78) | |||
| Potential Upside | 13.19 |
Quantum BioPharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Quantum BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Quantum BioPharma's standard deviation. In reality, there are many statistical measures that can use Quantum BioPharma historical prices to predict the future Quantum BioPharma's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.42) | |||
| Total Risk Alpha | (2.02) | |||
| Treynor Ratio | (0.73) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Quantum BioPharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Quantum BioPharma February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.72) | |||
| Mean Deviation | 6.2 | |||
| Coefficient Of Variation | (721.29) | |||
| Standard Deviation | 9.47 | |||
| Variance | 89.63 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (1.42) | |||
| Total Risk Alpha | (2.02) | |||
| Treynor Ratio | (0.73) | |||
| Maximum Drawdown | 59.29 | |||
| Value At Risk | (12.78) | |||
| Potential Upside | 13.19 | |||
| Skewness | 2.08 | |||
| Kurtosis | 7.24 |
Quantum BioPharma Backtested Returns
Quantum BioPharma maintains Sharpe Ratio (i.e., Efficiency) of -0.095, which implies the firm had a -0.095 % return per unit of risk over the last 3 months. Quantum BioPharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Quantum BioPharma's Variance of 89.63, risk adjusted performance of (0.09), and Coefficient Of Variation of (721.29) to confirm the risk estimate we provide. The company holds a Beta of 1.82, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Quantum BioPharma will likely underperform. At this point, Quantum BioPharma has a negative expected return of -0.91%. Please make sure to check Quantum BioPharma's total risk alpha, as well as the relationship between the kurtosis and day typical price , to decide if Quantum BioPharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Quantum BioPharma has insignificant reverse predictability. Overlapping area represents the amount of predictability between Quantum BioPharma time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Quantum BioPharma price movement. The serial correlation of -0.2 indicates that over 20.0% of current Quantum BioPharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 2.39 |
Quantum BioPharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Quantum BioPharma Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Quantum BioPharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Quantum BioPharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Quantum BioPharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Quantum BioPharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Quantum BioPharma price pattern first instead of the macroeconomic environment surrounding Quantum BioPharma. By analyzing Quantum BioPharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Quantum BioPharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Quantum BioPharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | Payables Turnover | 0.61 | 0.55 | 0.49 | Days Of Inventory On Hand | 126.96 | 114.26 | 101.57 |
Quantum BioPharma February 5, 2026 Technical Indicators
Most technical analysis of Quantum help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Quantum from various momentum indicators to cycle indicators. When you analyze Quantum charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (0.72) | |||
| Mean Deviation | 6.2 | |||
| Coefficient Of Variation | (721.29) | |||
| Standard Deviation | 9.47 | |||
| Variance | 89.63 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (1.42) | |||
| Total Risk Alpha | (2.02) | |||
| Treynor Ratio | (0.73) | |||
| Maximum Drawdown | 59.29 | |||
| Value At Risk | (12.78) | |||
| Potential Upside | 13.19 | |||
| Skewness | 2.08 | |||
| Kurtosis | 7.24 |
Quantum BioPharma February 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Quantum stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 19,157 | ||
| Daily Balance Of Power | (0.07) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 4.08 | ||
| Day Typical Price | 4.05 | ||
| Price Action Indicator | (0.09) |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quantum BioPharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in poverty. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Will Biotechnology sector continue expanding? Could Quantum diversify its offerings? Factors like these will boost the valuation of Quantum BioPharma. Anticipated expansion of Quantum directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Quantum BioPharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Quantum BioPharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Quantum BioPharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Quantum BioPharma's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.